Stocks · Health care · Biological Products, (No Diagnostic Substances)

Apogee Therapeutics, Inc.

APGE Clue Score20
United States Fiscal year ends December CIK 0001974640 Results filed 10 Aug 2026

What the insiders did Net selling

By person

8 insiders · 141 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Fairmount Funds Management LLC entity
Director
$50.00M (3)
$133.53M (1)
−$83.53M
340,855
0.4524%
$45.73M
0.0%
Michael Thomas Henderson
Chief Executive Officer
—
$37.96M (50) scheduled
−$37.96M
0
0.0000%
$0.00
−100.0%
Nimish P Shah
Director
$29.75M (1)
—
+$29.75M
1,750,000
2.32%
$234.80M
0.0%
Carl Dambkowski
Chief Medical Officer
—
$13.67M (57) scheduled
−$13.67M
0
0.0000%
$0.00
−100.0%
Jane Henderson
Chief Financial Officer
—
$2.38M (23) scheduled
−$2.38M
0
0.0000%
$0.00
−100.0%
Mark C. McKenna
Director
$990.78K (2)
—
+$990.78K
0
0.0000%
$0.00
—
William A Jones Jr
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Jennifer A. Fox
Director
—
—
—
0
0.0000%
$0.00
−100.0%